TAKAHASHI Hiromichi
| School of Medicine Department of Medicine | Associate Professor |
Researcher Information
Career
Research activity information
Paper
- Topological importance of CD8+ T-cell enrichment in the tumor microenvironment of classic Hodgkin lymphoma.
Hiromichi Takahashi; Shun Ito; Yoko Nakanishi; Katsuhiro Miura; Haruna Nishimaki; Masaru Nakagawa; Shimon Otake; Takashi Hamada; Takashi Koike; Kazuhide Iizuka; Shinobu Masuda; Tomohiro Nakayama; Tetsuo Shimizu; Naoya Ishibashi; Hirofumi Kogure; Hideki Nakamura
Annals of hematology, Jan. 2025 - TAFRO Syndrome: Guidance for Managing Patients Presenting Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis, Renal Insufficiency, and Organomegaly.
Katsuhiro Miura; Haruna Nishimaki-Watanabe; Hiromichi Takahashi; Masaru Nakagawa; Shimon Otake; Takashi Hamada; Takashi Koike; Kazuhide Iizuka; Yuuichi Takeuchi; Kazuya Kurihara; Toshihide Endo; Shun Ito; Hironao Nukariya; Takahiro Namiki; Yoshiyuki Hayashi; Hideki Nakamura
Biomedicines, Jun. 2024 - Use of finer needles for venipuncture increases in vitro haemolysis despite reducing persistent pain and nerve injury: a retrospective study.
Hiroshi Umemura; Hiromichi Takahashi; Yoshiaki Fukuda; Hitoshi Soma; Rumiko Aoki; Norihisa Takei; Tomohiro Nakayama
Annals of clinical biochemistry, Aug. 2023 - Clinical entity of cytomegalovirus disease in patients with malignant lymphoma on bendamustine therapy: a single-institution experience.
Noriyoshi Iriyama; Katsuhiro Miura; Hiromichi Takahashi; Masaru Nakagawa; Kazuhide Iizuka; Takashi Hamada; Takashi Koike; Kazuya Kurihara; Toshihide Endo; Tomohiro Nakayama; Yoshihiro Hatta; Hideki Nakamura
Leukemia & lymphoma, Jan. 2023 - [Thrombotic microangiopathy with gastrointestinal hemorrhage during carfilzomib therapy for multiple myeloma].
Shuhei Matsumoto; Hiromichi Takahashi; Takashi Hamada; Katsuhiro Miura; Masaru Nakagwa; Kazuya Kurihara; Toshihide Endo; Takashi Koike; Kazuhide Iizuka; Noriyoshi Iriyama; Tomohiro Nakayama; Yoshihiro Hatta; Hideki Nakamura
[Rinsho ketsueki] The Japanese journal of clinical hematology, 2023 - Pulmonary Veno-Occlusive Disease after Autologous Stem Cell Transplantation.
Takashi Hamada; Hiromichi Takahashi; Masaru Nakagawa; Hironao Nukariya; Shun Ito; Toshihide Endo; Kazuya Kurihara; Takashi Koike; Kazuhide Iizuka; Shimon Ohtake; Takashi Ichinohe; Toshiya Maebayashi; Katsuhiro Miura; Yoshihiro Hatta; Hideki Nakamura
Case reports in oncology, 2023 - Pirarubicin-based intensive chemotherapy followed by consolidative high-dose chemotherapies for peripheral T-cell lymphomas: A noncomparative phase 2 study.
Hiromichi Takahashi; Katsuhiro Miura; Masaru Nakagawa; Haruna Nishimaki; Shun Ito; Hironao Nukariya; Kazuya Kurihara; Toshihide Endo; Takashi Koike; Takashi Hamada; Kazuhide Iizuka; Shimon Ohatake; Noriyoshi Iriyama; Tomohiro Nakayama; Shinobu Masuda; Yoshihiro Hatta; Hideki Nakamura
Hematological oncology, Dec. 2022 - Ideal dose intensity of R-CHOP in diffuse large B-cell lymphoma.
Katsuhiro Miura; Hiromichi Takahashi; Masaru Nakagawa; Takashi Hamada; Yoshihito Uchino; Kazuhide Iizuka; Shimon Ohtake; Noriyoshi Iriyama; Yoshihiro Hatta; Hideki Nakamura
Expert review of anticancer therapy, Jun. 2022 - Clinical impact of central nervous system-directed therapies on intravascular large B-cell lymphoma: A single institution's experience.
Hiromichi Takahashi; Haruna Nishimaki; Yoko Nakanishi; Takashi Hamada; Masaru Nakagawa; Kazuhide Iizuka; Yoshihito Uchino; Noriyoshi Iriyama; Katsuhiro Miura; Tomohiro Nakayama; Shinobu Masuda; Yoshihiro Hatta; Hideki Nakamura
EJHaem, May 2022 - Relationship between Carnitine Deficiency and Tyrosine Kinase Inhibitor Use in Patients with Chronic Myeloid Leukemia.
Noriyoshi Iriyama; Katsuhiro Miura; Yoshihito Uchino; Hiromichi Takahashi; Masaru Nakagawa; Kazuhide Iizuka; Takashi Hamada; Takashi Koike; Kazuya Kurihara; Tomohiro Nakayama; Masami Takei; Yoshihiro Hatta; Hideki Nakamura
Chemotherapy, Nov. 2021 - Efficacy of introducing electronic cigarettes in smoker's polycythemia(和訳中)
飯塚 和秀; 伊藤 駿; 忽滑谷 寛直; 遠藤 聖英; 栗原 一也; 小池 隆; 濱田 高志; 中川 優; 内野 慶人; 高橋 宏通; 三浦 勝浩; 入山 規良; 八田 善弘; 中山 智祥; 武井 正美
日本血液学会学術集会, Sep. 2021 - 新規治療薬時代以降に診断された多発性骨髄腫患者における治療モダリティーと予後の変遷
吉田 努; 入山 規良; 内野 慶人; 高橋 宏通; 中川 優; 濱田 高志; 飯塚 和秀; 小池 隆; 栗原 一也; 遠藤 聖英; 野口 夕利花; 三浦 勝浩; 八田 善弘; 中山 智祥; 武井 正美
日大医学雑誌, Feb. 2021 - Absolute Lymphocyte Counts After Lenalidomide Initiation may Predict the Prognosis of Patients With Relapsed or Refractory Multiple Myeloma.
Masaru Nakagawa; Noriyoshi Iriyama; Takuto Ishikawa; Katsuhiro Miura; Yoshihito Uchino; Hiromichi Takahashi; Takashi Hamada; Kazuhide Iizuka; Takashi Koike; Kazuya Kurihara; Tomohiro Nakayama; Yoshihiro Hatta; Masami Takei
Cancer diagnosis & prognosis, 2021 - Maintenance Therapy With Bortezomib and Dexamethasone for Transplant-ineligible Patients With Multiple Myeloma.
Yurika Noguchi; Noriyoshi Iriyama; Hiromichi Takahashi; Yoshihito Uchino; Masaru Nakagawa; Takashi Hamada; Kazuhide Iizuka; Takashi Koike; Kazuya Kurihara; Toshihide Endo; Tsutomu Yoshida; Katsuhiro Miura; Tomohiro Nakayama; Yoshihiro Hatta; Masami Takei
Cancer diagnosis & prognosis, 2021 - 難治性免疫・アレルギー疾患の病態の解明と新規治療法の開発
岡山 吉道; 佐野 有隆; 豊島 翔太; 三木 寿美; 武富 芳隆; 坂本 朋美; 李 賢鎬; 齋藤 修; 村上 誠; 田杭 真帆; 伊東 真奈; 遠藤 嵩大; 丹羽 悠介; 葉山 惟大; 藤田 秀樹; 高橋 宏通; 三浦 勝浩; 濱田 岳志; 中川 優; 飯塚 和秀; 内野 慶人; 入山 規良; 小池 隆; 栗原 一也; 都築 広; 長澤 洋介; 長塚 靖子; 岩田 光浩; 北村 登; 丸岡 秀一郎; 福田 麻佐美; 山田 志保; 黒澤 雄介; 伊藤 亮治; 八田 善弘; 中山 智祥; 武井 正美; 徳橋 泰明; 權 寧博; 照井 正
日本大学医学部総合医学研究所紀要, Dec. 2020 - びまん性大細胞型B細胞リンパ腫への形質転換をきたしたCD5陽性節性濾胞辺縁帯リンパ腫
小池 隆; 入山 規良; 中川 優; 高橋 宏通; 濱田 高志; 内野 慶人; 三浦 勝浩; 八田 善弘; 中山 智祥; 武井 正美
臨床血液, Mar. 2020 - Increased Arbekacin Clearance in Patients With Febrile Neutropenia.
Takahiro Nakayama; Masayuki Chuma; Naohiro Tochikura; So Iwabuchi; Shinichiro Suzuki; Chiaki Matsumoto; Toru Imai; Takashi Hamada; Masaru Nakagawa; Hiromichi Takahashi; Yoshihito Uchino; Katsuhiro Miura; Noriyoshi Iriyama; Yoshihiro Hatta; Masami Takei; Takahisa Kimura
Therapeutic drug monitoring, Feb. 2020, Refereed, Not invited - [Transformation of CD5-positive nodal marginal zone lymphoma to diffuse large B-cell lymphoma].
Takashi Koike; Noriyoshi Iriyama; Masaru Nakagawa; Hiromichi Takahashi; Takashi Hamada; Yoshihito Uchino; Katsuhiro Miura; Yoshihiro Hatta; Tomohiro Nakayama; Masami Takei
[Rinsho ketsueki] The Japanese journal of clinical hematology, 2020 - Aggressive CD4-CD8-CD45RA+CCR10- Primary Cutaneous Peripheral T-cell Lymphoma, Not Otherwise Specified: A Case Report.
Natsumi Ikumi; Hideki Fujita; Tadashi Terui; Hiromichi Takahashi; Katsuhiro Miura; Yoshihiro Hatta; Masami Takei
Acta dermato-venereologica, Nov. 2019, Refereed, Not invited - 特徴的な染色体転座を有するALL細胞の変異遺伝子の解析
内野 慶人; 濱田 高志; 高橋 宏通; 入山 規良; 八田 善弘; 中山 智祥; 武井 正美
日大医学雑誌, Aug. 2019 - MPC-1 expression in myeloma cells is associated with the efficacy of bortezomib therapy.
Kazuya Kurihara; Noriyoshi Iriyama; Katsuhiro Miura; Yoshihito Uchino; Hiromichi Takahashi; Masaru Nakagawa; Kazuhide Iizuka; Takashi Hamada; Takashi Koike; Yoshihiro Hatta; Tomohiro Nakayama; Masami Takei
Medical oncology (Northwood, London, England), Jul. 2019, Refereed, Not invited - [Acute sensory neuropathy associated with Hodgkin's lymphoma: a case study].
Yuki Yokota; Kazutaka Mitsuke; Hiroko Minami; Akihiko Morita; Hiromichi Takahashi; Satoshi Kamei
Rinsho shinkeigaku = Clinical neurology, Jun. 2019 - Conjunctival lymphomas in Japanese monozygotic twins: A case report.
Naoya Ishibashi; Satoshi Sugaya; Hiromichi Takahashi; Haruna Nishimaki; Yoko Nakanishi; Yoshiaki Chinen; Toshiya Maebayashi
Oncology letters, Jan. 2019 - Thrombopoietin Levels During Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia.
Takashi Hamada; Noriyoshi Iriyama; Hiromichi Takahashi; Katsuhiro Miura; Yoshihito Uchino; Masaru Nakagawa; Yoshihiro Hatta; Masami Takei
Clinical drug investigation, Sep. 2018, Refereed, Not invited - 少量pomalidomideでstringent complete responseに到達した多発性骨髄腫
遠藤聖英; 濱田高志; 大竹志門; 中川 優; 内野慶人; 高橋宏通; 三浦勝浩; 入山規良; 小池 隆; 栗原一也; 佐藤紘子; 八田善弘; 武井正美
臨床血液, May 2018, Refereed, Not invited - Enhanced perforin expression associated with dasatinib therapy in natural killer cells.
Noriyoshi Iriyama; Hiromichi Takahashi; Katsuhiro Miura; Yoshihito Uchino; Masaru Nakagawa; Yoshihiro Hatta; Masami Takei
Leukemia research, May 2018, Refereed, Not invited - One percent chlorhexidine-alcohol for preventing central venous catheter-related infection during intensive chemotherapy for patients with haematologic malignancies.
Shimon Ohtake; Hiromichi Takahashi; Masaru Nakagawa; Yoshihito Uchino; Katsuhiro Miura; Noriyoshi Iriyama; Tomohiro Nakayama; Yoshihiro Hatta; Masami Takei
Journal of infection and chemotherapy, Apr. 2018, Refereed, Not invited
Lead - Impact of interventions by an antimicrobial stewardship program team on appropriate antimicrobial therapy in patients with bacteremic urinary tract infection.
Mitsuru Yanai; Maiko Ogasawara; Yuta Hayashi; Kiyozumi Suzuki; Hiromichi Takahashi; Atsushi Satomura
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, Mar. 2018 - The standard international prognostic index for predicting the risk of CNS involvement in DLBCL without specific prophylaxis.
Naoto Tomita; Masahiro Yokoyama; Wataru Yamamoto; Reina Watanabe; Yutaka Shimazu; Yasufumi Masaki; Saburo Tsunoda; Chizuko Hashimoto; Kayoko Murayama; Takahiro Yano; Rumiko Okamoto; Ako Kikuchi; Kazuo Tamura; Kazuya Sato; Kazutaka Sunami; Hirohiko Shibayama; Rishu Takimoto; Rika Ohshima; Hiromichi Takahashi; Yukiyoshi Moriuchi; Tomohiro Kinoshita; Masahide Yamamoto; Ayumi Numata; Hideaki Nakajima; Ikuo Miura; Kengo Takeuchi
Leukemia & lymphoma, Jan. 2018 - Retrospective evaluation of the clinical characteristics associated with Corynebacterium species bacteremia.
Mitsuru Yanai; Maiko Ogasawasa; Yuta Hayashi; Kiyozumi Suzuki; Hiromichi Takahashi; Atsushi Satomura
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2018 - [Achievement of a stringent complete response with low-dose pomalidomide monotherapy in a multiple myeloma patient].
Toshihide Endo; Takashi Hamada; Shimon Otake; Masaru Nakagawa; Yshihito Uchino; Hiromichi Takahashi; Katsuhiro Miura; Noriyoshi Iriyama; Takashi Koike; Kazuya Kurihara; Hiroko Sato; Yoshihiro Hatta; Msamai Takei
[Rinsho ketsueki] The Japanese journal of clinical hematology, 2018 - Clinical effect of immunophenotyping on the prognosis of multiple myeloma patients treated with bortezomib.
Noriyoshi Iriyama; Katsuhiro Miura; Yoshihiro Hatta; Sumiko Kobayashi; Yoshihito Uchino; Daisuke Kurita; Hitomi Sakagami; Hiromichi Takahashi; Masashi Sakagami; Yujin Kobayashi; Masaru Nakagawa; Shimon Ohtake; Yoshikazu Iizuka; Masami Takei
Oncology letters, May 2017, Refereed, Not invited - 1α-Dihydroxyvitamin D3 and retinoic acid increase nuclear vitamin D receptor expression in monocytic THP-1 cells
Hikaru Uchida; Yuichiro Hasegawa; Hiromichi Takahashi; Makoto Makishima
Anticancer Research, Dec. 2016, Refereed, Not invited - A cyclin D1-negative mantle cell lymphoma with an IGL-CCND2 translocation that relapsed with blastoid morphology and aggressive clinical behavior.
Kurita D; Takeuchi K; Kobayashi S; Hojo A; Uchino Y; Sakagami M; Ohtake S; Takahashi H; Miura K; Iriyama N; Sugitani M; Miyoshi H; Hatta Y; Ohshima K; Takei M
Virchows Archiv : an international journal of pathology, Oct. 2016, Refereed, Not invited - Plasma cell maturity as a predictor of prognosis in multiple myeloma
Noriyoshi Iriyama; Katsuhiro Miura; Yoshihiro Hatta; Yoshihito Uchino; Daisuke Kurita; Hiromichi Takahashi; Hitomi Sakagami; Masashi Sakagami; Yujin Kobayashi; Masaru Nakagawa; Shimon Ohtake; Yoshikazu Iizuka; Masami Takei
MEDICAL ONCOLOGY, Aug. 2016, Refereed, Not invited - Negative impact of concurrent overexpression of MYC and BCL2 in patients with advanced diffuse large B-cell lymphoma treated with dose-intensified immunochemotherapy.
Takahashi H; Miura K; Nakagawa M; Sugitani M; Amano Y; Kurita D; Sakagami M; Ohtake S; Uchino Y; Kodaira H; Iriyama N; Kobayashi S; Hojo A; Kobayashi Y; Hirabayashi Y; Kusuda M; Hatta Y; Nakayama T; Takei M.
Leukemia and Lymphoma, Apr. 2016, Refereed, Not invited
Lead - Clinical efficacy and safety of arbekacin for high-risk infections in patients with hematological malignancies
Katsuhiro Miura; Masaru Nakagawa; Hiromichi Takahashi; Yoshihito Uchino; Hitomi Kodaira; Noriyoshi Iriyama; Masashi Sakagami; Shimon Ohtake; Sumiko Kobayashi; Atsuko Hojo; Daisuke Kurita; Yujin Kobayashi; Machiko Kusuda; Yukio Hirabayashi; Yoshihiro Hatta; Masami Takei
INTERNATIONAL JOURNAL OF HEMATOLOGY, Mar. 2016, Refereed, Not invited - Clinical significance of co-expression of MYC and BCL2 protein in aggressive B-cell lymphomas treated with a second line immunochemotherapy.
Miura K; Takahashi H; Nakagawa M; Izu A; Sugitani M; Kurita D; Sakagami M; Ohtake S; Uchino Y; Hojo A; Kodaira H; Yagi M; Kobayashi Y; Iriyama N; Kobayashi S; Kiso S; Hirabayashi Y; Hatta Y; Takei M.
Leukemia and Lymphoma, Oct. 2015, Refereed, Not invited - Higher Red Blood Cell Distribution Width Is an Adverse Prognostic Factor in Chronic-phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors.
Iriyama N; Hatta Y; Kobayashi S; Uchino Y; Miura K; Kurita D; Kodaira H; Takahashi H; Iizuka Y; Inoue M; Takei M
Anticancer research, Oct. 2015, Refereed, Not invited - Dose-intensified CHOP with rituximab (R-Double-CHOP) followed by consolidation high-dose chemotherapies for patients with advanced diffuse large B-cell lymphoma.
Kurita D; Miura K; Nakagawa M; Ohtake S; Sakagami M; Uchino Y; Takahashi H; Kiso S; Hojo A; Kodaira H; Yagi M; Hirabayashi Y; Kobayashi Y; Iriyama N; Kobayashi S; Hatta Y; Kura Y; Sugitani M; Takei M
Int J Hematol., Jun. 2015, Refereed, Not invited - Safety and efficacy of high-dose cyclophosphamide, etoposide and ranimustine regimen followed by autologous peripheral blood stem cell transplant for patients with diffuse large B-cell lymphoma.
Kobayashi Y; Hatta Y; Sugitani M; Hojo A; Nakagawa M; Kusuda M; Uchino Y; Takahashi H; Kiso S; Hirabayashi Y; Yagi M; Kodaira H; Kurita D; Miura K; Iriyama N; Kobayashi S; Kura Y; Horikoshi A; Sawada U; Takeuchi J; Takei M
Leuk Lymphoma, Nov. 2014, Refereed, Not invited - Diagnostic value of brain biopsy in intravascular large B-cell lymphoma mimicking progressive multifocal leukoencephalopathy: Case report
Yusuke Takamine; Natsumi Ikumi; Hajime Onoe; Misa Hayase; Yousuke Nagasawa; Masashi Sakagami; Kaita Sugiyama; Suguru Nakahawa; Yoshito Uchino; Hiromichi Takahashi; Yukio Hirabayashi; Takamasa Nozaki; Katsuhiro Miura; Hirotake Inomata; Noriyoshi Iriyama; Hidetaka Shiraiwa; Sumiko Kobayashi; Noboru Kitamura; Yoshihiro Hatta; Yoshihiro Matsukawa; Masami Takei
Japanese Journal of Clinical Immunology, 2014, Refereed, Not invited - Efficacy of a dose-intensified CHOP (Double-CHOP) regimen for peripheral T-cell lymphomas
Noriyoshi Iriyama; Hiromichi Takahashi; Yoshihiro Hatta; Katsuhiro Miura; Yujin Kobayashi; Daisuke Kurita; Yukio Hirabayashi; Atsuko Hojo; Hitomi Kodaira; Mai Yagi; Satomi Kiso; Yoshihito Uchino; Masaru Nakagawa; Machiko Kusuda; Sumiko Kobayashi; Akira Horikoshi; Yoshimasa Kura; Tetsuo Yamazaki; Umihiko Sawada; Jin Takeuchi
ONCOLOGY REPORTS, Feb. 2013, Refereed, Not invited - Efficacy of oral cytarabine ocfosfate and Etoposide in the treatment of elderly patients with higher-risk myelodysplastic syndromes compared to that in elderly acute myeloid leukemia patients.
Horikoshi A; Iriyama N; Hirabayashi Y; Kodaira H; Matsukawa Y; Uchino Y; Takahashi H; Hatta Y; Takeuchi J; Kobayashi S; Miura K
Chemotherapy, 2013, Refereed, Not invited - [Pathology of acute lymphoblastic leukemia].
Takahashi H; Takeuchi J
Nihon rinsho. Japanese journal of clinical medicine, Apr. 2012, Refereed, Not invited - Long-term follow-up of localized, primary gastric diffuse large B-cell lymphoma treated with rituximab and CHOP.
Kobayashi Y; Hatta Y; Hojo A; Kura Y; Uchino Y; Takahashi H; Kiso S; Hirabayashi Y; Yagi M; Kodaira H; Kurita D; Tanaka T; Miura K; Iriyama N; Kobayashi S; Sawada U; Sugitani M; Takeuchi J
Experimental and Therapeutic Medicine, Feb. 2012, Refereed, Not invited
MISC
- A novel fusion gene involving PDGFRB and GCC2 in a chronic eosinophilic leukemia patient harboring t(2;5)(q37;q31).
Noriyoshi Iriyama; Hiromichi Takahashi; Hiromu Naruse; Katsuhiro Miura; Yoshihito Uchino; Masaru Nakagawa; Kazuhide Iizuka; Takashi Hamada; Yoshihiro Hatta; Tomohiro Nakayama; Masami Takei
Molecular genetics & genomic medicine, 07 Apr. 2019, Refereed, Not invited
Lead - Clinical Significance of Co-Expression of MYC and BCL2 Protein in Advanced Diffuse Large B-Cell Lymphoma Treated with a Dose-Intensified Immunochemotherapy
Hiromichi Takahashi; Sumiko Kobayashi; Katsuhiro Miura; Daisuke Kurita; Yoshihiro Hatta; Masahiko Sugitani; Shimon Otake; Masaru Nakagawa; Masashi Sakagami; Yoshihito Uchino; Hitomi Kodaira; Noriyoshi Iriyama; Machiko Kusuda; Atsuko Hojo; Mai Yagi; Yukio Hirabayashi; Yujin Kobayashi; Tomohiro Nakayama; Masami Takei
BLOOD, Dec. 2015, Not refereed, Not invited - Induced differentiation of human myeloid leukemia cells into M2 macrophages by combined treatment with retinoic acid and 1α,25-dihydroxyvitamin D3.
Takahashi H; Hatta Y; Iriyama N; Hasegawa Y; Uchida H; Nakagawa M; Makishima M; Takeuchi J; Takei M
PLoS One, 19 Nov. 2015, Refereed, Not invited
Lead - 造血幹細胞移植(内科領域)】 リンパ腫と造血幹細胞移植 当施設の治療経験も含めて
高橋宏通、中山智祥
日大医学雑誌, 01 Oct. 2015, Refereed, Not invited - Clinical Significance of Arbekacin Sulfate for High-Risk Infections Among Patients with Hematological Malignancies
Katsuhiro Miura; Satomi Kiso; Masaru Nakagawa; Hiromichi Takahashi; Yoshito Uchino; Hitomi Kodaira; Noriyoshi Iriyama; Masashi Sakagami; Shimon Ohtake; Sumiko Kobayashi; Atsuko Hojo; Mai Yagi; Daisuke Kurita; Yujin Kobayashi; Machiko Kusuda; Yukio Hirabayashi; Yoshihiro Hatta; Masami Takei
BLOOD, Dec. 2014, Not refereed, Not invited - Efficacy of a Dose-Intensified CHOP (Double-CHOP) Regimen for Peripheral T-Cell Lymphomas
Hiromichi Takahashi; Noriyoshi Iriyama; Yoshihiro Hatta; Katsuhiro Miura; Yujin Kobayashi; Daisuke Kurita; Yukio Hirabayashi; Atsuko Hojo; Hitomi Kodaira; Mai Yagi; Satomi Kiso; Yoshihito Uchino; Masaru Nakagawa; Machiko Kusuda; Sumiko Kobayashi; Akira Horikoshi; Yoshimasa Kura; Tetsuo Yamazaki; Umihiko Sawada; Jin Takeuchi
BLOOD, Nov. 2012, Not refereed, Not invited - Obesity Is a Poor Prognostic Factor In Acute Promyelocytic Leukemia (APL)
Yoshihiro Hatta; Akira Horikoshi; Daisuke Kurita; Sumiko Kobayashi; Yujin Kobayashi; Yoshimasa Kura; Hitomi Kodaira; Yasuyuki Inoue; Katsuhiro Miura; Satomi Kiso; Hiromichi Takahashi; Hikari Ishizuka; Toshitake Tanaka; Mai Yagi; Atsuko Hojo; Yukio Hirabayashi; Yoshihito Uchino; Noriyoshi Iriyama; Umihiko Sawada; Jin Takeuchi
BLOOD, Nov. 2010, Not refereed, Not invited
Books and other publications
Lectures, oral presentations, etc.
- Dose-intensified Double-THP-COP regimen followed by ASCT for PTCL: a prospective phase II trial.
高橋宏通、三浦勝浩、中川優、内野慶人、伊藤 駿、忽滑谷寛直、栗原一也、遠藤聖英、小池 隆、濱田高志、飯塚和秀、入山規良、八田善弘、中山智祥、武井正美
第82回日本血液学会学術集会, Oct. 2020, Not invited - アファチニブが奏功したEGFR exon19欠失を伴う原発不明腺癌の一例
第16回日本臨床腫瘍学会学術集会, Jul. 2018, Not invited - 新規薬剤時代における多発性骨髄腫に対する大量エトポシドを用いたPBSCCの有効性、安全性の検討
第40回日本造血細胞移植学会総会, Feb. 2018, Not invited - 進行期高悪性度リンパ腫に対する超大量メソトレキセート療法の有効性、安全性の検討
髙橋宏通
第78回日本血液学会学術集会, Oct. 2016, Not invited - Clinical Significance of Co-Expression of MYC and BCL2 Protein in Advanced Diffuse Large B-Cell Lymphoma Treated with a Dose-Intensified Immunochemotherapy
Hiromichi Takahashi
57th ASH Annual Meeting and Exposition, Dec. 2015, Not invited - Up-front intensive chemotherapy (R-Double-CHOP regimen) followed by HDC/ASCT in mantle cell lymphoma
髙橋宏通
第77回日本血液学会学術集会, Oct. 2015, Not invited
